Search results
Results from the WOW.Com Content Network
The Jewish Encyclopedia connects the two civil wars raging during the last decades of the first century BC, one in Judea between the two Hasmonean brothers Hyrcanus II and Aristobulus II, and one in the Roman republic between Julius Caesar and Pompey, and describes the evolution of the Jewish population in Rome:
In 49 BC Antipater prompted Hyrcanus to side with Julius Caesar during Caesar's Civil War. Following his victory, Caesar bestowed the title of ethnarch on Hyrcanus and epitropos (or Procurator) on Antipater. A few years later, Antipater appointed his sons Phasael and Herod military governors of Jerusalem and the Galilee respectively. [5]
During the siege of Alexandria in 47 BCE, the lives of Julius Caesar and his protégé Cleopatra were saved by 3,000 Jewish troops sent by Hyrcanus II and commanded by Antipater, whose descendants Caesar made kings of Judea. [108]
Gaius Julius Caesar [a] (12 July 100 BC – 15 March 44 BC) was a Roman general and statesman. A member of the First Triumvirate, Caesar led the Roman armies in the Gallic Wars before defeating his political rival Pompey in a civil war, and subsequently became dictator from 49 BC until his assassination in 44 BC.
After Julius Caesar defeated Pompey at the Battle of Pharsalus, Antipater sided with Caesar during the Roman Civil War. During Caesar's Egyptian campaign, Antipater joined Mithridates of Pergamon's army marching to rescue Caesar in Alexandria. Caesar made him chief minister of Judea, as Judah became known to the Romans, with the right to ...
President-elect Donald Trump speaks to members of the media following a meeting at the US Capitol on Jan. 8, 2025 in Washington, DC. Credit - Valerie Plesch—Bloomberg via Getty Images
Religio licita has sometimes been taken as a formal recognition or charter originating with Julius Caesar and embodied by various pieces of Roman legislation pertaining to the Jews, conceived of as a coherent policy. [11]
A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 ...